Today we switch back to ADHD and I will be talking about adult ADHD. I'm an adult psychiatrist and I practiced in the military so this was one of the largest issues that I treated as many of my patients were younger folks, many of which struggled in school prior to joining the military. There isn't a lot of formal education on this topic and yet we see tons of online information of folks talking about how they have adult ADHD and that if you answer these few questions this way then you have adult ADHD, so there's a lot of misinformation out there on this topic. It's a topic that wasn't really discussed at all until the last few decades and many still deny its existence at all. I'm going to talk about it in depth on this episode and I think you will find it very interesting and hopefully different than what you may have heard before. We will dive much deeper than the DSM definition which is mostly designed for children, and I will talk about how someone's life with adult ADHD looks so that you can pick up on the subtleties and make the best diagnosis in order to treat patients with the best care possible. So please have a listen!
--------
1:22:04
--------
1:22:04
Quick Take #3: September Updates! Part 1: Old Drugs For New Indications (Ketamine, Strattera, Flexeril) And Some Antidepressants On The Horizon (Nelivaptan and Seltorexant)
Welcome back to my second episode covering several snippets of breaking news on psychiatric medications. In these episodes I don't deep dive like normal, but instead cover several important breaking news items that affect psychopharmacology and give my quick take on the news. Some of this will be trial results, FDA updates, interesting papers that were recently published, and anything else I can come up with. I have a ton of updates since the last episode. So much that I had to break it up into two episodes. The next one will be out next week. Today I'm going to talk about new approvals of old medications from new ketamines, KETARx and Nrx100, to Tonmya(r) (cyclobenzaprine) for fibromyalgia. Then, I'll also talk about some combination products containing atomoxetine (Strattera(r)) for obstructive sleep apnea. Lastly, I'll then go into a couple medications with new Phase II trial data for depression. First is a unique vasopressin 1b antagonist and the second is a selective orexin receptor antagonist. I do a bit more discussion on these topics than in the previous update episode because honestly I'm not happy about a lot of this and I want to use these new approvals to talk about the deeper issue of how these drug companies manipulate to make money. Please have a listen!
--------
1:06:19
--------
1:06:19
E56: Obesity Medicine: Medical Effects of Obesity and Assessing the Obese Patient
Today I will be presenting my second episode on obesity medicine. I will go over how obesity reeks havoc on every system in the body, what medical conditions are increased by being obese, the increased risk of psychiatric disorders from obesity, and the long list of cancers that are at increased risk from obesity. I think you all will be surprised just how much obesity impacts health. Many of you may not be aware of how linked obesity is with psychiatric illness. Also I think you will be surprised just how many types of cancer are affected and how strongly. After that I will talk about how to do a thorough assessment, basically the history and physical, for a patient with obesity. We need to rule out other causes, assess motivation for treatment, and assess common comorbidities. This is great foundational information that I think you will find super helpful!
--------
1:08:16
--------
1:08:16
E55: ADHD: Diagnosis, Comorbidities, and Differential
Flipping back to ADHD today, I continue with the background information. I'll go over how to diagnose. I'll go over the criteria but of course I'll be giving you the subtleties of how to flush that out. I'll also talk about both mental health and medical disorders that often go along with ADHD, and I'll talk about the long list of other diagnoses that may look like ADHD with a special focus on bipolar disorder.
--------
1:09:06
--------
1:09:06
E54: Obesity Medicine: Measurements, Rates, Trends, and Causes
Today I will start a new season of This Is Your Brain On Drugs Psychiatry Podcast. I mentioned the dual season of ADHD with Obesity Medicine and Lifestyle Psychiatry on the previous episode. Last week I started with ADHD and today I will start the series on Obesity Medicine. I'll do an introduction where I talk about measuring obesity, rates of obesity, trends over time, and etiologies of obesity. I think you will find the discussion on etiology to be especially interesting. I decided to include my lectures on lifestyle and nutritional psychiatry into this series as well as these treatments can treat obesity but also are very useful in treating depression, anxiety, and other psychiatric conditions. So, there will be a lot on those topics before I start talking about the medications to treat obesity. I'm really excited to do this season. It's the one that I've been waiting to do for a year, so I hope you enjoy!
Join Cody Armstrong as he takes you on an adventure through psychiatric medications and beyond, breaking down these oft misunderstood drugs into easy, concise, and digestible pearls with his patented punk rock flare and a healthy dose of real science. Come explore these drugs like never before in fascinating detail whether you are a student, nurse, doc, patient, or just want to learn more. Listen to episodes on the podcast platform of your choice, follow along on YouTube with ease with slides and audio, or download slides at no cost at www.punkrockpsychiatrist.com. This Is Your Brain on Drugs Psychiatry Podcast will never charge you, show you an ad, or take sponsorship dollars from anyone because that just wouldn't be punk rock!
Polska